1.515
-0.065 (-4.11%)
-0.065 (-4.11%)
Upgrade to Real-Time
Regular Market
Low
1.45
High
6.18
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.065 | -4.11% | 1.515 | 12:03:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.58 | 1.515 | 1.59 | 1.58 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.51 | 1.52 | 0.01 | 1 | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,133 | 517,025 | $ 1.55 | $ 802,369 | - | 1.45 - 6.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:03:49 | 750 | $ 1.515 | USD |
Period:
Draw Mode:
Hepion Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 115.48M | 76.23M | 76.12M | $ - | $ - | -2.23 | -1.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 4.35M | 1.00% |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.51 | 1.6578 | 1.4719 | 1.57 | 1,251,834 | 0.005 | 0.33% |
| 1 Month | 2.23 | 2.27 | 1.4719 | 1.78 | 2,348,147 | -0.715 | -32.06% |
| 3 Months | 1.78 | 2.3184 | 1.45 | 1.88 | 2,193,163 | -0.265 | -14.89% |
| 6 Months | 2.27 | 3.18 | 1.45 | 2.10 | 4,370,978 | -0.755 | -33.26% |
| 1 Year | 4.06 | 6.18 | 1.45 | 2.14 | 2,787,637 | -2.55 | -62.68% |
| 3 Years | 3.11 | 8.35 | 1.00 | 2.62 | 1,934,828 | -1.60 | -51.29% |
| 5 Years | 3.11 | 8.35 | 1.00 | 2.62 | 1,934,828 | -1.60 | -51.29% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, CRV431, is being developed to offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. |
